Iprofayile yekhampani
I-Innovita Biological Technology Co., Ltd. (kunye ne-subsidiaries yayo, eyaziwa ngokuba yi-"INNOVITA",) yinkampani ye-biotechnology egxile kuphando, uphuhliso, ukuveliswa kunye nokuthengiswa kwe-in vitro diagnostic iimveliso ze-POCT. Iquka i-Innovita (Tangshan) , Innovita (Beijing) kunye ne-Innovita (Guangzhou).
● Yasekwa ngo-2006
● Misela amaziko e-R&D eBeijing naseGuangzhou, kunye nesiseko semveliso eQian'an, Hebei


Iprofayile yekhampani
Yasekwa ngo-2006, i-INNOVITA iye yakha amaqonga amathandathu obugcisa afana ne-antigen & nokulungiswa kwe-antibody, inkcubeko yentsholongwane, igolide ye-colloidal, i-ELISA, i-chromatography ye-fluorescence, i-immunofluorescence, kwaye yenza iNkqubo ye-R & D yeSizwe ye-High-tech kwinkalo yophando lwesizwe lwezifo ezosulelayo kunye ezininzi. ezinye iiprojekthi zempilo yoluntu.Ngaphandle koko, i-INNOVITA inamalungelo awodwa abenzi bokuqanjwa kwelizwe ngaphezulu kweshumi kwaye iseka iziko le-R&D laseBeijing, iziko le-R&D laseGuangzhou, isiseko semveliso ye-Hebei.Ngeeworkshops ezinkulu ezicocekileyo, kunye nokumisela igolide ye-colloidal, i-ELISA, i-fluorescence chromatography, i-PCR, imigca yokuvelisa i-immunofluorescence, i-INNOVITA ifumene i-CE kunye ne-ISO13485 isatifikethi.
Okwangoku, iimveliso ze-INNOVITA ziqulethe iimvavanyo zokuxilongwa kokuphefumla, iimvavanyo zokuchuma, iimvavanyo ze-hepatitis, iimvavanyo ze-TORCH, iimvavanyo zentliziyo, iimvavanyo ze-renal kunye nokunye.Inethiwekhi yokuthengisa igubungele onke amaphondo kunye nemimandla yaseTshayina, kwaye yasasazeka kwi-Asia-mpuma ye-Asia, kuMbindi Mpuma, e-Afrika, eLatin America, kwi-European Union kunye neminye imimandla yaphesheya.I-INNOVITA ibambelela kwifilosofi yoshishino oluphakathi kwabathengi, kwaye ikhonza abathengi ngeemveliso ezichanekileyo nezifanelekileyo.Iimfuno zabathengi kukusukela INNOVITA.
Inkqubo yoPhuhliso
Ngo-2006
Ngo-2011
Ngo-2014
Ngo-2018
● Kuqaliswe intsebenziswano yobuchwephesha bamazwe ngamazwe.
Ngo-2019
Ngo-2020
● Ukuthunyelwa kumazwe/iingingqi ezingaphezu kwama-70.
● Kuwongwa ngeNdlela ePhakamileyo kwiNkongolo yeSizwe yeeNcomo zokuLwa i-COVID-19 Pandemic.
● Uvavanyo lwe-COVID-19 lwe-IgM/IgG lufumene uGunyaziso lokuSebenzisa oluNgxamisekileyo (EUA) yi-US FDA.
Ngo-2022
Amasebe

EBeijing R&D & Iziko leNtengiso
Ukusekwa:2006
Gxininisa:I-R&D, ukuvelisa, ukuthengiswa kwemveliso yokuxilongwa kwe-in-vitro, kubandakanywa amaqonga afana ne-immunodiagnosis, ukuxilongwa kwe-molecular, kunye ne-gene chips.
Qian'an Manufacturing & Logistic Centre
Ukusekwa:2011
Indawo:Ukugubungela indawo yeehektare ezili-150, malunga ne-8,000 ㎡ indawo yokusebenzela, exhotyiswe ngemigca emininzi yemveliso yegolide ye-colloidal, i-ELISA, i-PCR.
Isiqinisekiso:ISO 13485, CE, FDA, NMPA, njl.
Guangzhou R&D Centre
Ukusekwa:2020
Gxininisa:I-R&D yetekhnoloji ye-IVD
Amaqonga

Uthungelwano lweNtengiso
Emva kweminyaka yophuhliso, i-Innovita sele inokuthengiswa okupheleleyo kunye nenethiwekhi yenkonzo, kunye neendlela zokuthengisa ezigubungela amaphondo angama-32 kunye nemimandla kwi-China yonke, kwaye ithumele kwiimarike zehlabathi ezifana ne-Southeast Asia, Middle East, Afrika, Latin America, Europe, njl.
Uvavanyo lwe-Innovita 2019-nCoV Ab luboniswe kwiqonga likaxakeka lesizwe lamayeza kunye nezixhobo zonyango
Ngomhla wama-28 kuFebruwari, 2020, iNkulumbuso uLi Keqiang yahlola iqonga lesizwe likaxakeka lamayeza kunye nezixhobo zonyango ze-COVID-19.Uvavanyo lwe-Innovita 2019-nCoV Ab luboniswe njengovavanyo lokuqala lwe-antibody lwe-NMPA oluvunyiweyo lwe-IgM/IgG, olwaxelwa kwi-CCTV.


Uvavanyo lwe-Innovita 2019-nCoV Ab luqanjwe ngu-Academician Zhong Nanshan
● Ngemva kwemini ye-23 kaFebruwari 2020, u-Academician Zhong Nanshan wadiza ngexesha lokubonisana okude e-Guangzhou kunye neqela lezonyango lase-Guangdong elileqa ukuya kunceda uJingzhou ukuba uLawulo lweeMveliso zezoNyango lweSizwe luvume izixhobo ezimbini zovavanyo ezintsha ze-2019-nCoV, enye yazo. uveliswe ngu-Innovita (Tangshan) Biological Technology Co., Ltd.
● Ikhithi isebenzisa indlela yegolide ye-colloidal, ekwaziyo ukubona i-antibody ye-lgM kumzimba wesigulana.I-antibody ye-lgM inokubonwa ngomhla we-7 wosulelo lwesigulane okanye ngosuku lwe-3 luqala, oluluncedo kakhulu ekuxilongweni kwesigulane.UZhong Nanshan uthe: "Izigulana zinokuchongwa ngokukhawuleza ukuba zixilongwe kakuhle. Oku kunokusinceda ukuba sahlukanise ngokukhawuleza abantu abaqhelekileyo kubantu abosulelekileyo."

Advanced Collective Award

Ukulwa ubhubhane
